Is Sermorelin FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Sermorelin is FDA approved and how it is commonly categorized.
Overview
Sermorelin is a synthetic growth hormone releasing hormone (GHRH) analog historically used to stimulate the body’s natural production of growth hormone. It is commonly marketed today through peptide and hormone optimization clinics.
FDA Status Details
Sermorelin is classified as Not FDA Approved for current commercial prescription use. While an earlier FDA-approved product (Geref Diagnostic) existed for diagnostic purposes, Sermorelin is not currently FDA approved for anti-aging, fat loss, wellness, or hormone replacement treatment.
Clinical & Peptide Clinic Use
Sermorelin is now most commonly associated with compounding pharmacies and wellness clinics offering growth hormone optimization programs. There is no currently marketed FDA-approved branded prescription product for general hormone therapy use.
Compounding & Safety Considerations
Products marketed as Sermorelin through peptide clinics should not be treated as standard FDA-approved medications. Compounded products may vary in purity, dosing consistency, and manufacturing standards.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.